Articles with "vegf treatment" as a keyword



Photo by schluditsch from unsplash

Visual acuity outcomes of anti-VEGF treatment for neovascular age-related macular degeneration in clinical trials

Sign Up to like & get
recommendations!
Published in 2021 at "Japanese Journal of Ophthalmology"

DOI: 10.1007/s10384-021-00869-x

Abstract: Anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) has been evaluated in clinical trials. To select the best anti-VEGF drug and the best treatment regimen for nAMD, a thorough understanding of the characteristics of each… read more here.

Keywords: anti vegf; treatment; treatment neovascular; vegf treatment ... See more keywords
Photo by schluditsch from unsplash

Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 Report Number 19

Sign Up to like & get
recommendations!
Published in 2019 at "Ophthalmology Retina"

DOI: 10.1016/j.oret.2019.06.001

Abstract: Abstract Purpose To analyze best-corrected visual acuity (BCVA) outcomes after anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD). Design Prospective cohort study of participants enrolled in a clinical trial of oral… read more here.

Keywords: anti vegf; age related; treatment; study ... See more keywords
Photo by nci from unsplash

Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data

Sign Up to like & get
recommendations!
Published in 2022 at "BMJ Open"

DOI: 10.1136/bmjopen-2021-055478

Abstract: Aims The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections. The aims of this observational study… read more here.

Keywords: vegf treatment; 2013 2018; anti vegf; intravitreal injections ... See more keywords
Photo from wikipedia

Hyperrefective foci in diabetic macular edema with subretinal fluid: association with visual outcomes after anti-VEGF treatment.

Sign Up to like & get
recommendations!
Published in 2022 at "Ophthalmic research"

DOI: 10.1159/000525412

Abstract: INTRODUCTION To describe the hyperreflective foci (HRF) on optical coherence tomography angiography (OCTA) in diabetic macular edema (DME) with subretinal fluid (SRF) and explore the association of HRF in the outer retina with photoreceptor integrity… read more here.

Keywords: vegf treatment; anti vegf; subretinal fluid; outer retina ... See more keywords
Photo from wikipedia

Anti-VEGF Treatment in Corneal Diseases.

Sign Up to like & get
recommendations!
Published in 2020 at "Current drug targets"

DOI: 10.2174/1389450121666200319111710

Abstract: BACKGROUND Corneal neovascularization (CN) is a clue feature of different ocular pathological conditions and can lead to corneal edema and opacification with subsequent vision loss. Vascular endothelial growth factor (VEGF), which plays a key role… read more here.

Keywords: anti vegf; vegf agents; corneal; vegf ... See more keywords
Photo from wikipedia

The VEGF Treatment of AMD Switch Study (The vTAS Study)

Sign Up to like & get
recommendations!
Published in 2017 at "Asia-Pacific Journal of Ophthalmology"

DOI: 10.22608/apo.2017364

Abstract: Purpose: To evaluate the effect of aflibercept on anatomic and visual outcomes in patients with choroidal neovascularization (CNV) previously treated with intravitreal ranibizumab with persistent fluid on optical coherence tomography (OCT). Design: Prospective, open‐label study.… read more here.

Keywords: treatment amd; fluid; study; vegf treatment ... See more keywords
Photo from wikipedia

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms23116094

Abstract: Anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) has been FDA-approved in 2004, and since then has helped tens of thousands of patients worldwide to preserve vision. Still, treatment responses vary widely, emphasizing the need… read more here.

Keywords: vegf treatment; age related; neovascular age; anti vegf ... See more keywords
Photo from wikipedia

Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Personalized Medicine"

DOI: 10.3390/jpm13030546

Abstract: Background: The aim of this study was to analyze demographically stratified incidence rates of patients with diabetic macular edema (DME) commenced in anti-VEGF therapy, to study temporal trends, to report the proportion of patients in… read more here.

Keywords: vegf treatment; incidence; anti vegf; patients active ... See more keywords
Photo from wikipedia

Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment

Sign Up to like & get
recommendations!
Published in 2022 at "Turkish Journal of Ophthalmology"

DOI: 10.4274/tjo.galenos.2021.16578

Abstract: Objectives: To determine the prevalence of polypoidal choroidal vasculopathy (PCV) in intravitreal (IV) anti-vascular endothelial growth factor (anti-VEGF)-resistant neovascular age-related macular degeneration (nvAMD) cases. Materials and Methods: Eyes that were diagnosed as having active and… read more here.

Keywords: vegf treatment; pcv; ophthalmology; anti vegf ... See more keywords